Co-authored by Ana Vivancos, Principal Investigator of VHIO’s Cancer Genomics Group, and VHIO’s Director Josep Tabernero, a News & Views…
Josep Tabernero
The Coordination and Support Action “4.UNCAN.eu” had its official kick-off on September 8-9 2022 with a public event hosted by…
The multicenter randomized phase III BREAKWATER trial, spearheaded by VHIO, is the first to evaluate the combination of study drugs…
Founded by Cancer Research UK (CRUK) and the National Cancer Institute (NIH-NCI, USA) the Cancer Grand Challenges are internationally funded…
The “J-BID – José Baselga Innovative Disruption Program” has an investment of up to 6 million euros and aims to…
Announced today, the PEGASUS study will assess circulating tumor DNA in blood to identify micrometastases in patients with colon cancer….
Announced this week by the SOLTI academic Breast Cancer Research Group, the ACROPOLI phase II open-label single arm, non-randomized, multicenter…
Barcelona, May 25, 2021- Results from a survey published today in the European Society for Medical Oncology’s (ESMO) open access journal,…
Thursday, February 04 2021, not only celebrates World Cancer Day’s 21st birthday but also the final year of its ‘I…
Delivering on the European Society for Medical Oncology’s (ESMO) commitment to securing the best possible outcomes for people with cancer…
